Pre-exposure mpox vaccination campaigns aimed at GBTMSM+ and sex work communities: What worked in 2022 and what can we learn to strengthen future targeted vaccination campaigns to stigmatized communities in infodemic times?
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:1 publications
Grant number: 481268
Key facts
Disease
mpoxstart year
2023Known Financial Commitments (USD)
$374,950.93Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Greyson Devon, Schwandt MichaelResearch Location
CanadaLead Research Institution
University of British ColumbiaResearch Priority Alignment
N/A
Research Category
Infection prevention and control
Research Subcategory
Restriction measures to prevent secondary transmission in communities
Special Interest Tags
Gender
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Indigenous PeopleSexual and gender minoritiesSex workersOther
Occupations of Interest
Unspecified
Mpox Research Priorities
Policies for public health, disease control & community resilience
Mpox Research Sub Priorities
Risk communication & community engagement e.g. key populations
Abstract
Publicationslinked via Europe PMC
Last Updated:2 days ago
View all publications at Europe PMC